PINK:NUNZ

Nunzia Pharmaceutical Stock Insider Trading

> Drug Manufacturers - Specialty & Generic

Buy NUNZ

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 02, 2026

Nunzia Pharmaceutical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 122.97M and sold 109.17M NUNZ shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	122.97M shares
● Sell	109.17M shares
68% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 23, 2005 Buy	Class A Common Stock P-Purchase	Hitz Kingman L CFO	C-Suite Officer	55 555 Value: $5K
Mar 23, 2005 Buy	Class A Common Stock P-Purchase	Kron Roger Alan Chief Operating Officer	C-Suite Officer	55 555 Value: $5K
Mar 23, 2005 Buy	Class A Common Stock P-Purchase	Kron Roger Alan Chief Operating Officer	C-Suite Officer	55 555 Value: $5K
Mar 21, 2005 Buy	CLASS A COMMON STOCK (1) P-Purchase	Sandifer Robin M Director	Director	1 402 162 Value: $112.2K
Mar 21, 2005 Sell	OPTION J-Other	Sandifer Robin M Director	Director	1 000 000 Value: $60.0K
Mar 21, 2005 Sell	CONVERTABLE PROMISORY NOTE J-Other	Sandifer Robin M Director	Director	0 Value: $0
Mar 21, 2005 Buy	CLASS A COMMON SATOCK (1) P-Purchase	Sandifer Robin M Director	Director	3 181 663 Value: $254.5K
Mar 21, 2005 Buy	CLASS A COMMON STOCK (1) P-Purchase	Sandifer Robin M Director	Director	1 402 162 Value: $112.2K
Mar 21, 2005 Sell	OPTION J-Other	Sandifer Robin M Director	Director	1 000 000 Value: $60.0K
Mar 21, 2005 Sell	CONVERTABLE PROMISORY NOTE J-Other	Sandifer Robin M Director	Director	0 Value: $0
Mar 21, 2005 Buy	CLASS A COMMON SATOCK (1) P-Purchase	Sandifer Robin M Director	Director	3 181 663 Value: $254.5K
Mar 17, 2005 Sell	Class A Common Stock Option J-Other	Fossen William J 10 Percent Owner	10% Owner	18 300 000 Value: $0
Mar 17, 2005 Sell	Class A Common Stock Option J-Other	Fossen Matthew W Insider	Other	5 000 000 Value: $300.0K
Mar 17, 2005 Sell	Class A Common Stock Option J-Other	Fossen Matthew W Insider	Other	1 000 000 Value: $250.0K
Mar 17, 2005 Sell	Class A Common Stock Option J-Other	Fossen William J 10 Percent Owner	10% Owner	18 300 000 Value: $0
Mar 17, 2005 Sell	Class A Common Stock Option J-Other	Fossen Matthew W Insider	Other	5 000 000 Value: $300.0K
Mar 17, 2005 Sell	Class A Common Stock Option J-Other	Fossen Matthew W Insider	Other	1 000 000 Value: $250.0K
Mar 17, 2005 Buy	Common Shares	Hitz Kingman L Vice President, CFO	CEO / President	0 Value: $0
Mar 17, 2005 Buy	Common Shares	Hitz Kingman L Vice President, CFO	CEO / President	0 Value: $0
Jun 24, 2004 Sell	Class A Common Stock Option J-Other	Fossen William J Insider	Other	12 000 000 Value: $720.0K
Jun 24, 2004 Sell	Class A Common Stock Option J-Other	Fossen William J Insider	Other	12 000 000 Value: $720.0K
Jan 02, 2002 Sell	Class A Common Stock Option J-Other	Fossen William J Insider	Other	300 000 Value: $60.0K
Jan 02, 2002 Sell	Class A Common Stock Option J-Other	Fossen William J Insider	Other	300 000 Value: $60.0K
Dec 07, 2000 Sell	Class A Common Stock Option J-Other	Fossen William J Insider	Other	1 000 000 Value: $250.0K
Dec 07, 2000 Sell	Class A Common Stock Option J-Other	Fossen William J Insider	Other	1 000 000 Value: $250.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NUNZIA PHARMACEUTICAL CORPORATION

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical ...

Read Full Profile Here